Home : November 2012 : November 12, 2012 News : Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol

Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol

November 12, 2012

SAN FRANCISCO, Nov. 12, 2012 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will host a conference call with investors to discuss the positive Phase 3 clinical results announced by its partner AstraZeneca.  Howard Robin, president and chief executive officer, will host the...

http://www.prnewswire.com/news-releases/nektar-to-host-conference-call-to-discuss-the-positive-phase-3-clinical-results-for-naloxegol-178789071.html
Other Stories